First Trust NYSE Arca Biotechnology Index Fund
154 hedge funds and large institutions have $622M invested in First Trust NYSE Arca Biotechnology Index Fund in 2018 Q1 according to their latest regulatory filings, with 36 funds opening new positions, 51 increasing their positions, 37 reducing their positions, and 10 closing their positions.
260% more first-time investments, than exits
New positions opened: 36 | Existing positions closed: 10
150% more funds holding in top 10
Funds holding in top 10: 2 → 5 (+3)
133% more call options, than puts
Call options by funds: $4.67M | Put options by funds: $2.01M
38% more repeat investments, than reductions
Existing positions increased: 51 | Existing positions reduced: 37
25% more capital invested
Capital invested by funds: $497M → $622M (+$126M)
18% more funds holding
Funds holding: 130 → 154 (+24)
3.28% more ownership
Funds ownership: 40.9% → 44.18% (+3.3%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NA
Navellier & Associates
Reno,
Nevada
|
+$23.3M |
| 2 |
Wells Fargo
San Francisco,
California
|
+$16M |
| 3 |
Bank of America
Charlotte,
North Carolina
|
+$15.7M |
| 4 |
Morgan Stanley
New York
|
+$9.84M |
| 5 |
MIAN
Mariner Independent Advisor Network
Overland Park,
Kansas
|
+$4.75M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Goldman Sachs
New York
|
-$3.34M |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
-$2.27M |
| 3 |
HFS
HL Financial Services
Louisville,
Kentucky
|
-$1.78M |
| 4 |
HH
Hilltop Holdings
Dallas,
Texas
|
-$1.35M |
| 5 |
Cambridge Investment Research Advisors
Fairfield,
Iowa
|
-$1.31M |
FBT Hedge Fund Activity: Q1 2018 in Review
154 of the 4,363 institutional investors tracked by Wall St. Rank reported a position in First Trust NYSE Arca Biotechnology Index Fund (FBT) for Q1 2018, worth a combined $622M — up 25% from $497M a quarter earlier.
Buyers outnumbered sellers: 36 funds opened new FBT positions and 10 closed out — a net gain of 26 holders — while 51 added to existing stakes and 37 trimmed.
The largest buyer was Navellier & Associates, opening a new position worth an estimated $23.3M. The largest seller was Goldman Sachs, cutting an estimated $3.34M.
- 154 institutional investors held First Trust NYSE Arca Biotechnology Index Fund (FBT) as of Q1 2018, up from 130 in Q4 2017.
- Funds reported $622M of First Trust NYSE Arca Biotechnology Index Fund stock for Q1 2018, up 25% quarter-over-quarter.
- 36 funds opened new First Trust NYSE Arca Biotechnology Index Fund positions in Q1 2018 and 10 closed out, a net change of +26 holders.
- The largest First Trust NYSE Arca Biotechnology Index Fund buyer in Q1 2018 was Navellier & Associates, an estimated $23.3M added.
- The largest First Trust NYSE Arca Biotechnology Index Fund seller in Q1 2018 was Goldman Sachs, an estimated $3.34M sold.
Based on aggregated 13F filings for Q1 2018.